skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

About Michael


10+ years of experience

Michael Haydock | Pharma Intelligence
Director Michael Haydock oversees content production for cardiovascular and metabolic diseases as well as infectious disease and vaccine indications. In his role, Michael provides analysis and strategic recommendations on various disease markets through comparative assessment of marketed and pipeline products and patient-based forecasting.
His specialities include hepatitis B, hepatitis C, HIV, influenza, dengue, pneumococcal vaccines and meningococcal vaccines. In addition to producing analyses on various antiviral and vaccine indications, Michael has designed several primary research surveys, and is currently focused on refining data inputs and forecasting methodology. His greatest achievement is the development of an interactive, patient-based 10-year forecast for the early-phase RSV vaccines landscape – a particularly challenging task given the lack of currently approved vaccines.

He joined Informa as an analyst in 2012, having achieved a first-class degree in Natural Sciences (Immunology and Virology) from the University of Cambridge.

Analyst Articles

Articles by Michael